CN1076621A - Prostatitis medicine " Qianlie daxin " - Google Patents

Prostatitis medicine " Qianlie daxin " Download PDF

Info

Publication number
CN1076621A
CN1076621A CN 93102760 CN93102760A CN1076621A CN 1076621 A CN1076621 A CN 1076621A CN 93102760 CN93102760 CN 93102760 CN 93102760 A CN93102760 A CN 93102760A CN 1076621 A CN1076621 A CN 1076621A
Authority
CN
China
Prior art keywords
gram
grams
radix
patent medicine
medicine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 93102760
Other languages
Chinese (zh)
Inventor
史在新
史道生
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN 93102760 priority Critical patent/CN1076621A/en
Publication of CN1076621A publication Critical patent/CN1076621A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

A kind of oral Chinese patent medicine is used for treating acute prostatitis, subacute prostatitis and chronic prostatitis.It is with traditional Chinese animals and plants medical material: prescriptions such as Herba Patriniae, Rhizoma Polygoni Cuspidati, Rhizoma Dioscoreae Septemlobae, Pseudobulbus cremastrae seu pleiones, Herba Taraxaci, Radix Polygoni Multiflori, Squama Manis, succinum, Spora Lygodii, Caulis Akebiae, Radix Achyranthis Bidentatae, Myrrha, Semen Persicae, Flos Carthami, Cortex Moutan, Radix Paeoniae Rubra, Radix Notoginseng, Radix Glycyrrhizae uralensis, adopt traditional technology pill or system to loose.Medicament of the present invention is without any side effects, and to prostatitic treatment, clinical observation is evident in efficacy, is better than existing Chinese and western drugs.

Description

Prostatitis medicine " Qianlie daxin "
The present invention relates to a kind of Chinese patent medicine, it is the more efficiently new drug of a kind of existing treatment prostatitis medicine.
Prostatitis is one of between twenty and fifty common disease of male, accounts for the first place of male urinary system disease.Because antibacterials be difficult for to see through prostatic epithelium fat, enter prostatic vesicle and bring into play its effective therapeutical effect, so the medical scholar in China and foreign countries still feels thorny to this disease at present, all goal in research is turned to Chinese medicine.For example Yuan Shen passes through comprehensive classification, propose the 1-6 prescription of treatment chronic prostatitis, contain compositions such as Rhizoma Smilacis Glabrae, Rhizoma Curcumae, the Radix Astragali, Herba Epimedii, the Radix Linderae, though clinical efficacy still can, yet still need cooperate treatments such as hormone, antibiotics, be not the effect that relies on natural plant fully.The brave soup treatment in the few golden used compound recipe ground of king chronic prostatitis, used decoction is taken inconvenience, but also other Chinese patent medicines of clothes of will holding concurrently.Medicines such as usefulness Radix Salviae Miltiorrhizae, the Rhizoma Anemarrhenae, Cortex Phellodendri such as Zhang Zhengda, Zhang Shouqian, Yan Guorui carry out blood circulation promoting and blood stasis dispelling, disappear in the hope of inflammation, amass Chinese medicine hot, that detumescence is treating stranguria yet also need add in the side with cleansing, moreover decoction are still taken inconvenience.
The object of the invention is to overcome defective of the prior art provides a kind of sublimed preparation, pill made from natural Chinese medicine to become powder, and this medicine all has the obvious treatment effect to acute, subacute and chronic prostatitis.
The present invention comprises following component (by per 500 gram patent medicine): Herba Patriniae 10-45 gram, succinum 2-20 gram, Radix Notoginseng 3-18 gram, Flos Carthami 5-30 gram, Myrrha 10-30 gram, Caulis Akebiae 5-35 gram, Radix Paeoniae Rubra 10-60 gram, Cortex Moutan 10-20 gram, Radix Polygoni Multiflori 10-60 gram, Rhizoma Polygoni Cuspidati 10-60 gram, Squama Manis pearl 10-30 gram, Herba Taraxaci 10-60 gram, Radix Achyranthis Bidentatae 10-30 gram Rhizoma Dioscoreae Septemlobae 10-35 gram, thatch
Figure 931027608_IMG4
Mushroom 20-50 gram, Spora Lygodii 12-60 gram, Semen Persicae 10-30 gram, Radix Glycyrrhizae tip 6-20 gram utilizes traditional handicraft to make sublimed preparation, pill or powder, is a kind of endo-medicine.
Pharmacological mechanism of the present invention is according to traditional Chinese medical science heat-clearing and toxic substances removing, the principle of eliminating stasis and resolving masses, Radix Notoginseng in the side, Semen Persicae, Flos Carthami, Radix Paeoniae Rubra, Cortex Moutan, Squama Manis, succinum, Myrrha eliminating stasis and resolving masses and dredge the meridian passage, 5 are cleansed long-pending heat and are made with Rhizoma Polygoni Cuspidati, Herba Patriniae, Spora Lygodii, Caulis Akebiae and lose the corruption of smart place and excreted by urinary tract, the Radix Achyranthis Bidentatae detumescence is treating stranguria, the priming part of the body cavity below the umbilicus, housing the bladder, kidneys and bowels that goes directly, with all medicines, alleviate the key medicine of having a pain in the stem especially in the Radix Glycyrrhizae uralensis.
Indication of the present invention: acute prostatitis, subacute prostatitis, chronic prostatitis.
The present invention mainly acts on: eliminate a series of pathological reactions such as vertical pain of the puckery pain of the caused urinary tract of prostate inflammatory course, perineum and crissum or groin, testis, waist bone distending pain, rheuminess things such as losing the corruption of smart place is excreted rapidly, impel prostatitis to absorb, recover prostatic normal function.
Below be one of prescription of the present invention (by per 500 gram patent medicine): Herba Patriniae 15-30 gram, succinum 2-20 gram, Radix Notoginseng 3-12 gram, Flos Carthami 5-20 gram, Myrrha 10-20 gram, Caulis Akebiae 5-25 gram, Radix Polygoni Ciliinerve 12-25 gram, Cortex Moutan 10-25 gram, Radix Polygoni Multiflori 20-50 gram, Rhizoma Polygoni Cuspidati 20-40 gram, Squama Manis pearl 10-20 gram, Herba Taraxaci 20-50 gram, Radix Achyranthis Bidentatae 15-30 gram Rhizoma Dioscoreae Septemlobae 20-30 gram, thatch
Figure 931027608_IMG5
Mushroom 20-35 gram, Spora Lygodii 20-50 gram, Semen Persicae 15-25 gram, Radix Glycyrrhizae tip 10-20 gram.
Most preferred embodiment of the present invention, (by per 500 gram patent medicine): Herba Patriniae 40 grams, succinum 8 grams, Radix Notoginseng 16 grams, Flos Carthami 16 grams, Moschus 2 grams, Myrrha 20 grams, Caulis Akebiae 20 grams, Radix Paeoniae Rubra 24 grams, Cortex Moutan 20 grams, Radix Polygoni Multiflori 50 grams, Rhizoma Polygoni Cuspidati 40 grams, Squama Manis pearl 20 grams, Herba Taraxaci 50 grams, Radix Achyranthis Bidentatae 30 gram Rhizoma Dioscoreae Septemlobae 30 grams, thatch
Figure 931027608_IMG6
Mushroom 30 grams, Spora Lygodii 44 grams, Semen Persicae 20 grams, the Radix Glycyrrhizae tip 20 grams.
The usage and dosage that this is bright: the treatment chronic prostatitis, take patent medicine 3 grams, day clothes three times at every turn, boiled water takes.Acute and subacute prostatitis patient add 1/2nd and 1/3rd of former dosage.
The present invention is by 20 routine clinical observations, and wherein before the most special person 10 of the course of disease, the oldest person 58 years old observed more than 10 weeks, and it is 75% that improvement rate is treated in smelting, and the prostatic fluid person of being clearly better accounts for 55% toxicological experiment conclusion, belongs to the big a kind of medicine of safety range.
Typical case's case: yellow * *, the man, 39 years old, married, the disease of urinating 1 year, urinating, the end is dripping eventually, and groin and testis expand painful, the normal adularescent secretions of external orifice of urethra before and after urinating, thickness, amount is few, and is heavy when light when feeling symptom in vain, still can adhere to routine work, and antibiotic therapy does not have improvement March.Anus is examined prostate does not have obvious increase, and quality is harder, still flexible, and lobus lateralis dexter nodosity, but smooth surface have mild tenderness, and seminal vesicle does not touch.Examination of prostatic fluid: pyocyte is in heaps, erythrocyte a little, lecithin disappears.Be diagnosed as chronic prostatitis.It is oral that the prostatitis reaches new three grams, day clothes three times, treatment 4 week back symptoms disappear substantially, prostatic fluid takes a turn for the better, the 8th all symptom complete obiterations, prostatic fluid only have leukocyte a little, the back recovery from illness of 10 weeks is followed up a case by regular visits to and was not had recurrence in 1 year.
Following advantage of the present invention:
1, raw material sources of the present invention are abundant, and cost is lower, and curative effect is higher.
2, the present invention confirms by zoopery, and is without any side effects.
3, patent medicine of the present invention is taken simply, and is easy to carry, and the chronic patients long-term taking is easy to accept.
4, prostatitic treatment lacks method and special medicine at present, and the present invention contributes for this reason.

Claims (5)

1, the prostatitic new Chinese patent medicine-prostatitis of a kind of treatment reaches newly, it is characterized in that it comprises following component, (falling into a trap by per 500 gram patent medicine): Herba Patriniae 10-45 gram, succinum 2-20 gram, Radix Notoginseng 3-18 gram, Flos Carthami 5-30 gram, Myrrha 10-30 gram, Caulis Akebiae 5-35 gram, Radix Paeoniae Rubra 10-60 gram, Cortex Moutan 10-20 gram, Radix Polygoni Multiflori 10-60 gram, Rhizoma Polygoni Cuspidati 10-60 gram, Squama Manis pearl 10-30 gram, Herba Taraxaci 10-60 gram, Radix Achyranthis Bidentatae 10-30 gram Rhizoma Dioscoreae Septemlobae 10-35 gram, thatch
Figure 931027608_IMG1
Mushroom 20-50 gram, Spora Lygodii 12-60 gram, Semen Persicae 10-30 gram, Radix Glycyrrhizae tip 6-20 gram.
2, Chinese patent medicine as claimed in claim 1 is characterized in that it contains following component, (by per 500 gram patent medicine): Herba Patriniae 15-30 gram, succinum 2-20 gram, Radix Notoginseng 3-12 gram, Flos Carthami 5-20 gram, Myrrha 10-20 gram, Caulis Akebiae 5-25 gram, Radix Paeoniae Rubra 12-25 gram, Cortex Moutan 10-25 gram, Radix Polygoni Multiflori 20-50 gram, Rhizoma Polygoni Cuspidati 20-40 gram, Squama Manis pearl 10-20 gram, Herba Taraxaci 20-50 gram, Radix Achyranthis Bidentatae 15-30 gram Rhizoma Dioscoreae Septemlobae 20-30 gram, thatch
Figure 931027608_IMG2
Mushroom 20-35 gram, Spora Lygodii 20-50 gram, Semen Persicae 15-25 gram, Radix Glycyrrhizae tip 10-20 gram.
3, Chinese patent medicine as claimed in claim 1 is characterized in that: it comprises following component, (by per 500 gram patent medicine): Herba Patriniae 40 grams, succinum 8 grams, Radix Notoginseng 16 grams, Flos Carthami 16 grams, Moschus 2 grams, Myrrha 20 grams, Caulis Akebiae 20 grams, Radix Paeoniae Rubra 24 grams, Cortex Moutan 20 grams, Radix Polygoni Multiflori 50 grams, Rhizoma Polygoni Cuspidati 40 grams, Squama Manis pearl 20 grams, Herba Taraxaci 50 grams, Radix Achyranthis Bidentatae 30 gram , Rhizoma Dioscoreae Septemlobae 30 grams, thatch
Figure 931027608_IMG3
Mushroom 30 grams, Spora Lygodii 44 grams, Semen Persicae 20 grams, the Radix Glycyrrhizae tip 20 grams.
4,, be sublimed preparation or pill in this medicine in its feature as the described Chinese patent medicine of claim 1-3.
5,, it is characterized in that this medicine is a powder as the described Chinese patent medicine of claim 1-3.
CN 93102760 1993-03-25 1993-03-25 Prostatitis medicine " Qianlie daxin " Pending CN1076621A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 93102760 CN1076621A (en) 1993-03-25 1993-03-25 Prostatitis medicine " Qianlie daxin "

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 93102760 CN1076621A (en) 1993-03-25 1993-03-25 Prostatitis medicine " Qianlie daxin "

Publications (1)

Publication Number Publication Date
CN1076621A true CN1076621A (en) 1993-09-29

Family

ID=4984275

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 93102760 Pending CN1076621A (en) 1993-03-25 1993-03-25 Prostatitis medicine " Qianlie daxin "

Country Status (1)

Country Link
CN (1) CN1076621A (en)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1054530C (en) * 1996-04-26 2000-07-19 李建平 Qianliehuixiao pill for treating prostatitis and prostatic hyperplasia
CN1060061C (en) * 1995-01-29 2001-01-03 万麟 Pills for prostata disease
CN1075724C (en) * 1993-10-31 2001-12-05 罗俊红 Suppository for curing prostatosis
CN1294954C (en) * 2004-03-12 2007-01-17 天津中新药业集团股份有限公司隆顺榕制药厂 Medicine for treating urethra infestation and prostatitis and its preparation method
CN1331527C (en) * 2005-07-13 2007-08-15 凌沛学 Traditional Chinese medicinal prepn. for treating chronic prostatitis and prostatauxe, and its prepn. method
CN101229238B (en) * 2008-01-07 2010-12-08 包建宇 Chinese traditional medicine preparation for treating prostate disease
CN102526642A (en) * 2012-03-20 2012-07-04 南宁市品迪生物工程有限公司 Method for treating prostatitis comprehensively
CN102580005A (en) * 2012-03-23 2012-07-18 南宁市品迪生物工程有限公司 Zhuang ethnic group medical secret recipe for treatment of prostatitis
CN103720734A (en) * 2014-01-24 2014-04-16 严斯文 Medicament for treating prostatitis
CN104435908A (en) * 2013-09-16 2015-03-25 冯金秀 Traditional Chinese medicine for treating prostatitis

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1075724C (en) * 1993-10-31 2001-12-05 罗俊红 Suppository for curing prostatosis
CN1060061C (en) * 1995-01-29 2001-01-03 万麟 Pills for prostata disease
CN1054530C (en) * 1996-04-26 2000-07-19 李建平 Qianliehuixiao pill for treating prostatitis and prostatic hyperplasia
CN1294954C (en) * 2004-03-12 2007-01-17 天津中新药业集团股份有限公司隆顺榕制药厂 Medicine for treating urethra infestation and prostatitis and its preparation method
CN1331527C (en) * 2005-07-13 2007-08-15 凌沛学 Traditional Chinese medicinal prepn. for treating chronic prostatitis and prostatauxe, and its prepn. method
CN101229238B (en) * 2008-01-07 2010-12-08 包建宇 Chinese traditional medicine preparation for treating prostate disease
CN102526642A (en) * 2012-03-20 2012-07-04 南宁市品迪生物工程有限公司 Method for treating prostatitis comprehensively
CN102526642B (en) * 2012-03-20 2013-12-11 南宁市品迪生物工程有限公司 Method for treating prostatitis comprehensively
CN102580005A (en) * 2012-03-23 2012-07-18 南宁市品迪生物工程有限公司 Zhuang ethnic group medical secret recipe for treatment of prostatitis
CN104435908A (en) * 2013-09-16 2015-03-25 冯金秀 Traditional Chinese medicine for treating prostatitis
CN103720734A (en) * 2014-01-24 2014-04-16 严斯文 Medicament for treating prostatitis

Similar Documents

Publication Publication Date Title
CN1054530C (en) Qianliehuixiao pill for treating prostatitis and prostatic hyperplasia
CN103316174B (en) Traditional Chinese medicinal composition for treating acute cholecystitis and preparation method thereof
CN102284050B (en) Chinese medicine composition for treating infertility caused by cold uterus
CN102210844B (en) Chinese medicinal composition for treating chronic hepatitis and preparation method thereof
CN106729212B (en) Compound traditional Chinese medicine composition for treating acute stage of gout and application thereof
CN1076621A (en) Prostatitis medicine " Qianlie daxin "
CN100333757C (en) Compound traditional Chinese medicinal prepn. for preventing and treating uterus abnormal bleeding disease, and its prepn. method
CN100584354C (en) A medicine for treating zoster sequela neuralgia
CN101036741B (en) Medicine for treating cancer and preparing method therefor
CN101797325B (en) Medicament composition for treating gynecologic inflammation and preparation method and application thereof
CN101234184B (en) Orally-administered Chinese medicine composition for treating radiation proctitis
CN101204532B (en) Medicine for prostate disease and preparation method thereof
CN103341153B (en) Traditional Chinese medicine composition for treating raynaud disease
CN103055078A (en) Traditional Chinese medicine for treating ascites hepatoma and preparation method thereof
CN113144149A (en) Traditional Chinese medicine composition for treating cervical HPV virus infection
CN1241596C (en) Oral Chinese traditional medicine preparation for treating cystitis
CN104840891A (en) Traditional Chinese medicine preparation used for treating alcoholic cardiomyopathy and preparation method thereof
CN100418569C (en) Chinese medicine for treating prostatitis
CN109966453A (en) A kind of Chinese medicine preparation for treating gout
CN1078897A (en) " hepatitis B health " Chinese medicine preparation and preparation technology thereof
CN102228643A (en) Traditional Chinese medicine composition for treating chronic prostatitis
CN103386055A (en) Qianlieantong capsule and preparation method thereof
CN115804805B (en) Traditional Chinese medicine compound composition for treating ankylosing spondylitis and external medicine bag
CN111773292B (en) Traditional Chinese medicine composition for treating herpes zoster as well as preparation method and application thereof
CN102872353A (en) Medicament for treating hypertension dizzy

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C01 Deemed withdrawal of patent application (patent law 1993)
WD01 Invention patent application deemed withdrawn after publication